Home
Oxygenta Pharmaceutical Ltd Share Price History
Oxygenta Pharmaceutical Ltd
BSE : 21 Feb, 2025
80.85-1.6 (-2.0%)
Prev Close
82.5
Open Price
81.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
3695
Today's High / Low
81.1 / 80.8
52 WK High / Low
108.6 / 27.6
Market Price of Oxygenta Pharmaceutical Ltd
1M
1Y
3Y
5Y
Monitoring Oxygenta Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 8 |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Net Profit (Cr.) | -6 |
| BVPS | -26.84 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 0 |
| Op. Profit Mgn % | -51.78 |
| Net Profit Mgn % | -71.29 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Oxygenta Pharmaceutical Ltd
- Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
- Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.
- The Company is doing contract manufacturing work for APL and also having its own production.
- The Company is engaged in manufacture of bulk drugs.
- It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
Popular Search
FAQs for Oxygenta Pharmaceutical Ltd Share Price History
What are the key events that typically impact Oxygenta Pharmaceutical Ltd's share price history?
Key events that impact Oxygenta Pharmaceutical Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Oxygenta Pharmaceutical Ltd's share price history?
Stock splits reduce the nominal price of Oxygenta Pharmaceutical Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Oxygenta Pharmaceutical Ltd?
Dividends can influence Oxygenta Pharmaceutical Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Oxygenta Pharmaceutical Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Oxygenta Pharmaceutical Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Oxygenta Pharmaceutical Ltd’s share price history?
To understand Oxygenta Pharmaceutical Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
